HIV, Cambodia | HIV STD TESTING SINGAPORE™
HIV, Cambodia | HIV STD TESTING SINGAPORE™ @beautycambodia_com: HIV (human immunodeficiency virus)
Keywords: Hiv Cambodia, Cambodia Hiv, Hiv.
HIV is the abbreviation for the human immunodeficiency virus, which causes the acquired immunodeficiency syndrome
Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: HIV, Cambodia
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.
Realizing the Potential of Treatment as Prevention: Global ART Policy and Treatment Coverage
Mon, 29 Sep 2014 22:08:38 +0100 | Current HIV/AIDS Reports
This article reviews the antiretroviral therapy (ART) initiation criteria from published national guidelines for 94 countries (representing 86 % of global HIV burden) and compares them with the 2013 World Health Organization (WHO) ART guidelines. As of 31st of July 2014, 19 countries have adopted the WHO-recommended CD4 eligibility criteria of ≤500 cells/mm3, while seven have opted to treat irrespective of CD4 cell count (“test and treat”). Together, these 26 countries represent 27 % of 2013 global HIV burden. Additionally, test and treat is recommended for selected groups of HIV-positive individuals, namely, (a) people with tuberculosis in 58 countries, (b) pregnant women in 42 countries, (c) people with liver disease due to hepatitis B co-infection in 52 countries, (d) serodiscor...
EMA Panel Endorses Darunavir/Cobicistat Combo for HIVEMA Panel Endorses Darunavir/Cobicistat Combo for HIV
Mon, 29 Sep 2014 19:31:31 +0100 | Medscape Medical News Headlines
Rezolsta is intended for the treatment of antiretroviral therapy-naive and antiretroviral therapy-experienced adults with no darunavir-resistance-associated mutations. International Approvals (Source: Medscape Medical News Headlines)
Caffeine-infused weight loss underwear buzzless: FTC
Mon, 29 Sep 2014 19:09:18 +0100 | Reuters: Health
WASHINGTON (Reuters) - Bras, girdles and leggings infused with caffeine and sold as weight loss aids were more decaf than espresso, and the companies that sold them have agreed to refund money to customers and pull their ads, U.S. regulators said on Monday. (Source: Reuters: Health)
Africa: Improved Data On Community Health Workers Critical to Achieving Global Health Goals
Mon, 29 Sep 2014 14:12:21 +0100 | AllAfrica News: HIV-Aids and STDs
[PR Newswire]Cape Town, South Africa -Report by alliance of top US-based organizations urges nations to maximize impact of CHWs by defining core competencies (Source: AllAfrica News: HIV-Aids and STDs)
HIV Special Surveillance Report: HIV Risk, Prevention, and Testing Behaviors, National HIV Behavioral Surveillance System, Men Who Have Sex with Men, 20 U.S. Cities, 2011
Mon, 29 Sep 2014 13:00:00 +0100 | CDC HIV/AIDS Prevention
This report summarizes results from cycle 3 of NHBS data collection conducted among MSM in 2011. In order to monitor risk behaviors and the use of prevention services—including HIV testing—among those considered at risk of acquiring HIV, this report focuses on sexually active participants who reported their HIV status as HIV-negative or unknown (Source: CDC HIV/AIDS Prevention)
Liberia: Liberian Doctor Defends 3-5 Days Ebola Treatment With HIV Drug
Mon, 29 Sep 2014 11:42:16 +0100 | AllAfrica News: Health and Medicine
[FrontPageAfrica]"When the patients come early, and they are put on this medication, they recover within three to five days. This medication is not specifically for HIV/AIDS, I want this to be clear; but the Anti Retrovirus agent that is used to treat other virus illnesses like hepatitis 'B'. But it is one of those medications that are combined with two or three other medications to treat HIV/AIDS, so it should not really be called an HIV/AIDS drugs." - Dr. G. Gorbee Logan, County Health Officer, Tubmanburg Hospital (Source: AllAfrica News: Health and Medicine)
Increase in CD4 Count Among New Enrollees in HIV CareIncrease in CD4 Count Among New Enrollees in HIV Care
Mon, 29 Sep 2014 08:54:33 +0100 | Medscape Today Headlines
After the CDC revised HIV testing guidelines, are we noticing increased CD4 counts among newly diagnosed HIV patients? JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Today Headlines)
HIV-Infected Individuals at Risk for Atherosclerotic EventsHIV-Infected Individuals at Risk for Atherosclerotic Events
Mon, 29 Sep 2014 08:54:29 +0100 | Medscape Today Headlines
Identifying HIV-infected individuals at risk for CHD can be extremely challenging. AIDS (Source: Medscape Today Headlines)
South Africa: SANDF Slammed for HIV Discrimination - Again
Mon, 29 Sep 2014 08:45:50 +0100 | AllAfrica News: HIV-Aids and STDs
[Daily Maverick]Again, the courts have ruled against South African National Defence Force's (SANDF) treatment of members and recruits with HIV. In a ruling on Friday, the SANDF's actions were called an assault on the dignity of HIV-positive recruits that disregards a previous judgment and sets a bad example for the nation. Andisiwe Dwenga hopes she's the last person to suffer the unfair discrimination. By GREG NICOLSON. (Source: AllAfrica News: HIV-Aids and STDs)
Africa: Landmark HIV Diagnostic Access Program Will Save $150m
Mon, 29 Sep 2014 08:44:05 +0100 | AllAfrica News: HIV-Aids and STDs
[Global Fund]Roche has announced a major Global Access Program to sharply lower the price of HIV viral load tests in low- and middle-income countries. This new initiative creates a ceiling price of US$9.40 per test, and will reduce Roche's average price by more than 40% in low- and middle-income countries. When fully implemented, the Global Access Program is projected to save more than US$150 million in costs over the next five years. (Source: AllAfrica News: HIV-Aids and STDs)